A contract has been penned down by the firm Bavarian Nordic with the European Commission’s Health Preparedness and Response Authority (HERA). European Commission stated that the agreement would allow buying 109, 090 doses of the third-generation vaccines against the ongoing monkeypox outbreak. The EU shared the information on June 14.
The EU further noted that the agreement had been signed so that the vaccines are made available rapidly to the member states where the cases of the outbreak are witnessing a hike.
EC Vice-President for Promoting our European Way of Life, Margaritis Schinas, while speaking on the outbreak, asserted, “Securing vaccines quickly and efficiently to all the EU member states in response to the monkeypox outbreaks is our moral duty & a concrete deliverable of the our tangible capacity to protect people”.
Following the above statement, the Vice-President of EC further added, “We will spare no effort in building a true genuine strong European Health Union at the service of our citizens. This is why for the first time we are using the EU budget, through the EU4Health programme, to directly purchase vaccines for member states”.
Health and Digital Executive Agency (HaDEA) of the European Commission has purchased a third-generation vaccine for and on behalf of HERA against monkeypox. Although, the 3rd generation vaccine for the current time is only authorised to the European Commission.
The delivery has already started based on the number of cases, the organisation further informed.
During the last week, Germany witnessed a rise of 15% in cases of the monkeypox outbreak. Meanwhile, the United Kingdom has recorded 104 total cases of the monkeypox.